Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,325 public trials 1,974 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Recruiting

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

NCT06150664

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +37 more
Locations
  • D&H Cancer Research Center Margate, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • University Cancer & Blood Center Athens, Georgia, United States
View Trial Details
Recruiting

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NCT06312176

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Ironwood Cancer & Research Centers ( Site 0066) Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center-Oncology ( Site 0004) Gilbert, Arizona, United States
  • Providence Medical Foundation-Oncology ( Site 0020) Fullerton, California, United States
  • Moores Cancer Center ( Site 0059) La Jolla, California, United States
View all 259 locations
View Trial Details
Recruiting

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

NCT06841354

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • USA Mitchell Cancer Institute ( Site 0090) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers ( Site 0036) Chandler, Arizona, United States
  • City of Hope ( Site 0097) Duarte, California, United States
  • City of Hope Lennar Foundation Cancer Center ( Site 0099) Irvine, California, United States
View all 267 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

NCT05894239

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Banner Health MD Anderson AZ Gilbert, Arizona, United States
  • Disney Family Cancer Center Burbank, California, United States
  • City of Hope Corona, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 192 locations
View Trial Details

Related conditions